Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.510 | 4.900 | 3.3900 |
| Révision: | $441.56M | $431.00M | -$40.56M |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | -2.900 | ||
| Révision: | $421.19M | $448.00M | -$59.19M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 2.000 | 2.800 | 0.8000 |
| Révision: | $545.06M | — | -$71.06M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.370 | 3.010 | 1.6400 |
| Révision: | $454.35M | $462.00M | $9.65M |
